John B. Harlow
President & COOMr. John B. Harlow, Jr. is President & COO of Larimar Therapeutics, Inc. from September 29, 2026. Mr. Harlow was Chief Commercial Officer of Esperion Therapeutics, Inc. from November 17, 2025 to September 2026. Mr. Harlow was an equity research analyst covering large cap pharmaceutical companies at Bank of America Merrill Lynch and started at Janssen Pharmaceuticals, Inc. as a sales representative and marketing communications specialist. Mr. Harlow serves as the Board of Advisor of Branchlab Inc. Mr. John was Chief Commercial Officer of Melinta Therapeutics, Inc. since March 29, 2021 until November 2025. Mr. Harlow served as Chief Commercial Officer of Baudax Bio Inc. He served as Executive Vice President of Commercial at Recro Pharma, Inc since February 2018. He has many years of branded pharmaceutical experience, including commercial leadership roles in marketing, sales and operations. He joined Recro as served as Vice President of Marketing in October 2016. From 2015 to 2016, Mr. Harlow served as the Vice President & General Manager of the Pain Business Unit for Endo Pharmaceuticals. Prior to Endo, Mr. Harlow spent over 3 years at Shionogi in roles of increasing responsibilities including Vice President, Sales and Marketing and Vice President of Sales, Training and Operations. Prior to joining Shionogi, Mr. Harlow was a Senior Director of Marketing at King Pharmaceuticals where he oversaw the pain portfolio that was ultimately acquired by Pfizer. Mr. Harlow spent over 6 years with Novartis Pharmaceuticals in sales management and marketing leadership roles in the Neuroscience business unit. Earlier in his career, Mr. Harlow was an equity research analyst at Merrill Lynch and a sales representative at Janssen Pharmaceuticals - a Johnson and Johnson company. Earlier in his career, Mr. Harlow held roles of increasing responsibility at Endo, Inc., Shionogi, Inc., Pfizer, Inc. (NYSE: PFE) and Novartis AG. He earned a BS in Biology from Lehigh University and an M.B.A. in Pharmaceutical Management & Marketing from The Stillman School of Business at Seton Hall University.
Positions
- Company NameLarimar Therapeutics, Inc.Stock CodeLRMRPositionPresident & COOColleagues
- CSCarole S. Ben-MaimonCEO & Director
- JTJoseph TruittIndependent Chairman of the Board
- MCMichael CelanoSecretary & CFO
- GSGopi ShankarChief Development Officer
- JBJohn BermanVice President of Finance & Administration
- JSJonathan S. LeffIndependent Director
- FEFrank Edward ThomasIndependent Director
- TEThomas Edward HamiltonIndependent Director
